Stock listing
Clarity Pharmaceuticals Ltd.
Selected listing: 1F4 · FWB · EUR · DE
Clarity Pharmaceuticals Ltd. (Frankfurt:1F4), Health Technology. Latest release Aug 5, 2026: Clarity Pharmaceuticals Announces SECuRE Trial Update on 8 GBq…
- Ticker
- Frankfurt:1F4
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- Frankfurt
- Currency
- EUR
Latest news from Clarity Pharmaceuticals Ltd.
Clarity Pharmaceuticals Announces SECuRE Trial Update on 8 GBq 67Cu-SAR-bisPSMA dose level with two additional complete responses
August 5, 2026
SECuRE update
August 4, 2026
Data on SAR-bisPSMA to be presented at EANM
June 28, 2026
Clarity receives $9.8 million R&D tax incentive refund
May 14, 2026
Clarity signs a Commercial Manufacturing Agreement for Cu-64 SAR-bisPSMA with Nucleus RadioPharma
April 14, 2026
Research Clarity Pharmaceuticals Ltd.
Clarity Pharmaceuticals Ltd. company profile
View the public company page for Clarity Pharmaceuticals Ltd. on 6ix.
Clarity Pharmaceuticals Ltd. news
Read company news and market updates connected to Clarity Pharmaceuticals Ltd..
Clarity Pharmaceuticals Ltd. investor events
Find investor webinars, events, and replay context for Clarity Pharmaceuticals Ltd..
Alternate listings
CU6:ASX
AU · AUD
Alternate listing for Clarity Pharmaceuticals Ltd.; the primary context on this page is 1F4:FWB.
CLRPF:OTC
US · USD
Alternate listing for Clarity Pharmaceuticals Ltd.; the primary context on this page is 1F4:FWB.
1F4:TRADEGATE
DE · EUR
Alternate listing for Clarity Pharmaceuticals Ltd.; the primary context on this page is 1F4:FWB.
1F4:DUS
DE · EUR
Alternate listing for Clarity Pharmaceuticals Ltd.; the primary context on this page is 1F4:FWB.